Home » Stocks » XXII » Company

22nd Century Group, Inc. (XXII)

Stock Price: $3.16 USD -0.02 (-0.63%)
Updated Jul 23, 2021 4:00 PM EDT - Market closed
22nd Century Group, Inc.
Founded 1998
Industry Drug Manufacturers-Specialty & Generic
Sector Healthcare
Employees 67

Contact Details

Address:8560 Main Street
Williamsville, NY 14221
United States
Phone 716 270 1523

Stock Information

Ticker Symbol XXII
Fiscal Year January - December
Reporting Currency US Dollars
CIK Code 0001347858
CUSIP Number 90137F103
ISIN Number US90137F1030
Employer ID 98-0468420

Company Description

22nd Century Group, Inc., a biotechnology company, develops plant-based solutions for the life science, consumer product, and pharmaceutical markets.

It develops very low nicotine content tobacco and cigarette products under the Moonlight and Moonlight Menthol names; and SPECTRUM research cigarettes for use in independent clinical studies.

22nd Century Group, Inc. has collaboration with Keygene N.V. to develop hemp/cannabis plants for exceptional cannabinoid profiles and other superior agronomic traits for medical, therapeutic, and agricultural uses, as well as other applications.

22nd Century Group, Inc. was founded in 1998 and is headquartered in Williamsville, New York.

Key Executives

James A. MishChief Executive Officer
Michael J. ZercherPresident and Chief Operating Officer
John E. FranzinoVice President of Administrative, Chief Financial Officer and Treasurer
Mei KuoDirector of Communications and Investor Relations
Steven PrzybylaGeneral Counsel and Corporate Secretary
Henry Sicignano III, M.B.A., MBAConsultant
James C. MorrisonTechnical Advisor and Regulatory Affairs Consultant